Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|December 17, 2013
Long-term treatment of hyperphosphatemia with bixalomer in Japanese hemodialysis patientsTadao Akizawa, Chisato Kameoka, Yuichiro Kaneko, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|April 12, 2014
Randomized controlled trial of bixalomer versus sevelamer hydrochloride in hemodialysis patients with hyperphosphatemiaTadao Akizawa, Hideki Origasa, Chisato Kameoka, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|July 1, 2014
Dose-finding study of bixalomer in patients with chronic kidney disease on hemodialysis with hyperphosphatemia: a double-blind, randomized, placebo-controlled and sevelamer hydrochloride-controlled open-label, parallel group studyTadao Akizawa, Hideki Origasa, Chisato Kameoka, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|February 15, 2017
Long-Term Safety and Efficacy of Bixalomer in Hyperphosphatemic Patients With Chronic Kidney Disease Not on DialysisTadao Akizawa, Junko Tsukada, Chisato Kameoka, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|November 30, 2016
Bixalomer in Hyperphosphatemic Patients With Chronic Kidney Disease Not on Dialysis: Phase 3 Randomized TrialTadao Akizawa, Hideki Origasa, Chisato Kameoka, et al.
Kidney International Reports|January 18, 2018
NPT-IIb Inhibition Does Not Improve Hyperphosphatemia in CKDTobias E Larsson, Chisato Kameoka, Ikumi Nakajo, et al.
Microorganisms|July 30, 2025
Selenium Metabolizing Capabilities of 12 Bacterial Strains Isolated from Urban Environmental SamplesMasashi Kuroda, Iori Ishimoto, Chisato Kameoka, et al.
Kidney International Reports|July 13, 2023
The Effects of Peroxisome Proliferator-Activated Receptor-Delta Modulator ASP1128 in Patients at Risk for Acute Kidney Injury Following Cardiac SurgeryJ W Olivier van Till, Hiroyuki Nojima, Chisato Kameoka, et al.
Pageof 1